Accelerate Diagnostics Inc organizacji Cena/wartość księgowa
Jaka jest wartość Cena/wartość księgowa organizacji Accelerate Diagnostics Inc?
Wartość Cena/wartość księgowa organizacji Accelerate Diagnostics Inc to -2.27
Jaka jest definicja Cena/wartość księgowa?
Wskaźnik ceny do sprzedaży(Price to book ratio) reprezentuje stosunek wartości akcji spółki do wartości księgowej na akcję.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Cena/wartość księgowa firm w Health Care sektor na NASDAQ w porównaniu do Accelerate Diagnostics Inc
Czym się zajmuję organizacja Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Firmy z cena/wartość księgowa podobne do Accelerate Diagnostics Inc
- Wartość Cena/wartość księgowa organizacji Aquis Entertainment to -2.31
- Wartość Cena/wartość księgowa organizacji Zelira Therapeutics to -2.30
- Wartość Cena/wartość księgowa organizacji Infinity Pharmaceuticals to -2.29
- Wartość Cena/wartość księgowa organizacji Acreage to -2.28
- Wartość Cena/wartość księgowa organizacji CytomX Therapeutics Inc to -2.28
- Wartość Cena/wartość księgowa organizacji Holista CollTech to -2.27
- Wartość Cena/wartość księgowa organizacji Accelerate Diagnostics Inc to -2.27
- Wartość Cena/wartość księgowa organizacji Bridgemarq Real Estate Services to -2.27
- Wartość Cena/wartość księgowa organizacji Biophytis SA to -2.25
- Wartość Cena/wartość księgowa organizacji Optiva to -2.25
- Wartość Cena/wartość księgowa organizacji Calumet to -2.25
- Wartość Cena/wartość księgowa organizacji Excellon Resources to -2.25
- Wartość Cena/wartość księgowa organizacji AA Plc to -2.24